ManpowerGroup Has Appointed Lidia Fonseca To Board
ManpowerGroup appoints Pfizer executive Lidia Fonseca to its board, for digital transformation and technology leadership growth.
ManpowerGroup has elected Lidia Fonseca, executive vice president and chief digital and technology officer at Pfizer, to its board of directors, effective November 1, 2026.
“Lidia brings a rare combination of technology leadership, business transformation experience and a clear understanding of how AI can create value at scale. Her strategic perspective, operational expertise and track record of leading change strengthen our ability to evolve the business and advance our transformation strategy. We are pleased to welcome her to our Board,” said Jonas Prising, Chair and CEO of ManpowerGroup.
Fonseca served as Pfizer’s Executive Vice President and Chief Digital and Technology Officer from January 2019 to April 2026. She led the company’s enterprise AI, digital, data and technology strategy. Her responsibilities also included Learning & Development and Business Process Excellence.
She built Pfizer’s enterprise AI programme from inception and scaled it across the organisation. According to ManpowerGroup, the initiative contributed to significant growth and cost savings.
Fonseca currently serves as a senior adviser to Pfizer’s CEO. She is also on the Board of Directors of Medtronic plc.
Before joining Pfizer, Fonseca spent a decade in diagnostics. She served as Senior Vice President and Chief Information Officer at Quest Diagnostics and previously held the same role at LabCorp. She began her career in operations and executive leadership roles at Philips Healthcare.
Fonseca holds a bachelor’s degree from the University of California, Berkeley. She also has an MBA and a Master of Business Informatics from the Rotterdam School of Management at Erasmus University.